ORGS — Orgenesis Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.56m
- $17.16m
- $1.04m
Brief: Orgenesis Says Entered Into Clinical Study Agreement With Edith Wolfson Medical Center
Brief: Orgenesis Announces Collaboration With Hospital Infantil Universitario Niño Jesús, Madrid, To Establish Point Of Care Center
Brief: Orgenesis Announces Stock Repurchase Plan Of Up To $10 Million
Brief: Orgenesis Announces Cell-Based Vaccine Platform Targeting COVID-19 And Other Existing And Emerging Viral Diseases
Brief: Orgenesis First Quarter 2020 Revenue Increases 348% To $1.9 Million
Brief: Orgenesis Inc Files For Offering Of 3.2 Million Shares Of Co's Common Stock By Selling Stockholders
Brief: Orgenesis Announces Agreement To Acquire Assets Of Tamir Biotechnology
Brief: Orgenesis Announces Joint Venture Agreement With Revatis
Brief: Orgenesis Received Approval From Regulators To Continue Working In Co's Research And Development Labs During Pandemic
Brief: Orgenesis Says Selling Stockholders May Offer Up To 3.2 Mln Shares Of Common Stock
Brief: Orgenesis Announces Collaboration With The John Hopkins University
Orgenesis climbs after selling its unit to Catalent
Brief: Catalent To Acquire Cell Therapy Co Masthercell Global For $315 Mln
Brief: Orgenesis Announces Agreement For The Sale Of Masthercell Global
Brief: Orgenesis Inc Announces Addition Of University Of California, Davis (UC Davis) To Point Of Care Network
Brief: Orgenesis And Theracell To Launch Point Of Care Cell And Gene Therapy Centers Within Hygeia Group's Hospital Network In Greece
Brief: Orgenesis Q3 Revenue Increases 46% To A Record $9.1 Mln
Brief: Orgenesis Appoints Bala S. Manian To Its Scientific Advisory Board
Development Agreement With Accellix